Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science London (22K09390)
Japan Society for the Promotion of Science London (24K02574)
- License Information
-
More Information
Article History
Received: 18 January 2026
Accepted: 18 March 2026
First Online: 21 April 2026
Declarations
:
: The authors declare no financial competing interests. Zeon BioSolutions Inc. provided RNA-seq services at no cost; the company had no role in study design, data interpretation, manuscript preparation, or the decision to publish.
: Ethical approval was not required because this study used established, publicly available patient-derived cell lines and did not involve identifiable human participants.
